Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2000
03/29/2000CN1050835C 1,5-benzodiazepine derivatives and its preparation process and use in medicine
03/29/2000CN1050749C Anti-inflammatory analogesic plaster
03/28/2000US6043366 Useful in treating disorders involving the orphanin fq(a seventeen amino acid long peptide) receptor.
03/28/2000US6043285 Treating alzheimer's disease
03/28/2000US6043283 Administering tyramine compound to patient to inhibit injury, destruction or death of neurons
03/28/2000US6043280 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
03/28/2000US6043265 Isoxazolyl endothelin antagonists
03/28/2000US6043261 Pyrrolodino imidines useful as nitric oxide synthase inhibitors
03/28/2000US6043255 Muscarinic antagonists
03/28/2000US6043250 Treating or preventing inflammatory diseases
03/28/2000US6043244 Method and composition for treating migraine
03/28/2000US6043240 Useful as antipsychotic and analgesic agents
03/28/2000US6043239 Heterocyclic compounds
03/28/2000US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6043053 Wnt-3 polynucleotides
03/28/2000CA2177821C Prolyl endopeptidase inhibitors
03/28/2000CA2126086C Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
03/28/2000CA2014453C Adamantane-derivatives in the prevention and treatment of cerebral ischemia
03/28/2000CA1340937C Piperidine compounds and their preparation and use
03/23/2000WO2000015806A1 Atp synthase subunit homolog
03/23/2000WO2000015805A1 Use of protein kinase kiaa0551 as pharmaceutical
03/23/2000WO2000015798A2 Mammalian transforming growth factor beta - 9 (ztgfss9)
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015794A1 Human cell junction pdz protein
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015614A1 Novel compounds
03/23/2000WO2000015611A1 Branched alkyl pyrrolidine-3-carboxylic acids
03/23/2000WO2000015609A1 Azetidine derivatives, preparation and medicines containing them
03/23/2000WO2000015263A1 Expandible microparticle intracellular delivery system
03/23/2000WO2000015261A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use
03/23/2000WO2000015245A2 Stable liquid formulations of botulinum toxin
03/23/2000WO2000015227A1 Use of 3,4-dihydro-6, 7-dimethoxy-alpha-phenyl- n,n-bis [(2,3,4-trimethoxyphenyl) ethyl]-1-i soquinolineacetamide in the manufacture of a medicament for the reduction of motor dysfunction
03/23/2000WO2000015225A1 Treatment of depression
03/23/2000WO2000015223A1 Treatment of persistent pain
03/23/2000WO2000015220A1 A new composition
03/23/2000WO2000015219A1 A new composition
03/23/2000WO2000015218A1 A new composition
03/23/2000WO2000015217A1 A new composition
03/23/2000WO2000015216A1 Therapeutic compositions (ii)
03/23/2000WO2000015208A2 New use of immunosupressants for mmp-mediated diseases
03/23/2000WO2000015206A2 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes
03/23/2000WO2000015205A2 Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
03/23/2000WO2000015204A2 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers
03/23/2000WO2000015196A1 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
03/23/2000WO2000015195A1 Quick release pharmaceutical compositions of drug substances
03/23/2000WO2000008013A3 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
03/23/2000WO2000006135A3 Cholinergic agents in the treatment of presbyopia
03/23/2000WO2000000599A3 Composition for the induction of apoptosis in target cells
03/23/2000WO2000000198A8 Piperidine derivatives having effects on serotonin related systems
03/23/2000WO1999065539A9 Tumescent solution
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease
03/23/2000DE19843301A1 Pulverförmige, modifizierte Füllstoffe enthaltende Kautschukpulver, Verfahren zu ihrer Herstellung und Verwendung Powdery, modified fillers containing rubber powder, process for their preparation and use
03/23/2000DE19842903A1 New Eschscholzia californica extract useful as analgesic, obtained by extraction of foliage with aqueous alcohol contains alkaloids californin and californidin
03/23/2000CA2706859A1 Mammalian transforming growth factor beta - 9
03/23/2000CA2344441A1 Expandible microparticle intracellular delivery system
03/23/2000CA2343838A1 Atp synthase subunit homolog
03/23/2000CA2343761A1 Treatment of depression
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342585A1 A new composition
03/23/2000CA2342341A1 A new composition
03/23/2000CA2342301A1 Human cell junction pdz protein
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
03/23/2000CA2342233A1 A new composition
03/23/2000CA2342223A1 A new composition
03/23/2000CA2341440A1 Novel compounds
03/23/2000CA2339941A1 Use of cyclic esters of r-3-hydroxybutyrate for treatment of metabolic and neural degenerative disorders
03/23/2000CA2339354A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use
03/22/2000EP0987552A2 Diarylsulfonylurea binding proteins
03/22/2000EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/22/2000EP0987248A1 Amide derivatives and their therapeutic use
03/22/2000EP0986562A1 Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands
03/22/2000EP0986559A1 1,6-naphthyridine anti-convulsants
03/22/2000EP0986558A2 Ergoline derivatives and their use as somatostatin receptor antagonists
03/22/2000EP0986556A1 Treatment of central nervous system disorders with selective estrogen receptor modulators
03/22/2000EP0986555A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same
03/22/2000EP0986552A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
03/22/2000EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
03/22/2000EP0986400A1 Integrin ligand, human mindin
03/22/2000EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals
03/22/2000EP0986390A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
03/22/2000EP0986389A1 Novel process
03/22/2000EP0986379A1 Use of substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury
03/22/2000EP0620814B1 Novel piprazine carboxamides
03/22/2000CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells
03/22/2000CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
03/22/2000CN1248254A Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for treatment of neurodegenerative and CNS-trauma related conditions
03/22/2000CN1248249A 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
03/22/2000CN1248248A Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as AMPA-receptor antagonists
03/22/2000CN1248246A 4-aminoethoxyindazole derivatives
03/22/2000CN1248177A Coated particles, method of making and using
03/22/2000CN1247759A Hemiplegia treating pill
03/22/2000CN1247750A Medicine for neurasthenia and its preparation
03/22/2000CN1050601C Novel aminoalkyl benzothiazolinone, its prepn. and medical composition containing the compound
1 ... 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 ... 1833